Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Clinterooon Sep 20, 2013 7:21pm
210 Views
Post# 21756360

RE:Where's our old crew...

RE:Where's our old crew...
I'm here too stock ; )   I bought more after the Wanbang release. I thought that should have helped the share price much more than it did. Obviously that didn't happen but it gave me a chance to buy more. I am now all-in with SBM... for better or worse.

The only problem with the Wanbang release is that there wasn't really any details. We dont know how much money up front, what milesotones need to be met, likelihood of meeting them, when the $9.5 million is paid, etc. Anyway, like most things the details are obviously important and so I think that is why the share price did not appreciate more.

Like most here, I am obviously confident that management is doing a good job and the deals will materialize... otherwise I would sell. Perhaps this weeks movement is an indication that the deals are going to be finalized sooner rather than later.

I have been in this stock for almost 2 years and it has been frustrating at times... hopefully our time has come.

Bullboard Posts